Illuminating the Consequentialist Logic of Harm Reduction After Overdose Through a Hypothetical Randomized Trial

Click to increase image sizeClick to decrease image size

This article refers to:

Revive and Refuse: Capacity, Autonomy, and Refusal of Care After Opioid Overdose

ACKNOWLEDGMENTS

Views presented here are solely those of the authors and do not represent views or positions of the US Department of Veterans Affairs.

DISCLOSURE STATEMENT

Dr. Kertesz attests to current ownership of stock in DexCom and Thermo Fisher, not exceeding 5% of assets. He attests to earning royalty income from the UpToDate medical reference service. He also reports his spouse privately holds stock in Merck, Johnson & Johnson and Abbot, not exceeding 10% of her assets.

Additional information

Funding

Dr. Riggs is supported by a career development award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (K23 AR080224).